2021 annual financial data
Chemomab Therapeutics Ltd. - American Depositary Shares 2021 Operating margin
Chemomab Therapeutics Ltd. - American Depositary Shares 2021 operating margin w…
Direct answer
Operating margin was Not calculable.
Operating income was -12,367,000 USD and net income was -12,478,000 USD.
Operating cash flow was -12,382,563 USD.
Get free Chemomab Therapeutics Ltd. - American Depositary Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -12,367,000 USD
- Net income
- -12,478,000 USD
- Operating cash flow
- -12,382,563 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Chemomab Therapeutics Ltd. - American Depositary Shares financial years